The inclusion in the State Register of Medicinal Remedies of Russian Federation of the pharmaceutical substance Ropivacaine HCl (API), produced by the company Excella GmbH & Co. KG (Germany), has been successfully completed in Russia. This pharmaceutical substance is used as a local anesthetic. Ropivacaine HCl is available in injectable grade intended for parenteral use.
For more information about the product visit our sales portal imcobuy: www.imcobuy.com or contact us.